Son is an experienced US Food and Drug Administration (FDA) lawyer, having spent almost 14 years in the industry as associate chief counsel for enforcement, associate chief counsel for devices and combination products, and senior counsel. Having worked on some of the most complex regulatory issues while at the FDA and in private practice, Son brings a practical, creative approach to solving problems. He advises a wide range of life sciences clients, with a focus on medical devices, pharmaceuticals, biotechnology, dietary supplements, food, cosmetics and combination-product companies. His practice spans all stages of the product life cycle, including premarket product development and launch strategy, clinical trials and preclinical testing, premarket submissions, product marketing and promotion, current good manufacturing practice, adverse event reporting, FDA inspections, recalls, and imports and exports. Son also advises clients on regulatory matters in connection with capital markets, financing and M&A transactions involving FDA-regulated entities.
